UK Trial Gives Voice to CLL Patients’ Experiences with Targeted Therapies
Traditionally, clinical trials report adverse events from a clinical perspective, but the patient’s experience with targeted therapies is often not fully considered, except in nonspecific patient-reported outcome studies. To address this gap, Dr. Dima El-Sharkawi
Consultant Haematologist, the Royal Marsden Hospital is conducting a trial in the UK, interviewing patients on targeted therapies for CLL.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in